LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,651 | -19.8% | 45,605 | -3.5% | 0.00% | 0.0% |
| Q2 2023 | $3,407,229 | -0.4% | 47,257 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $3,419,217 | +9.5% | 46,482 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $3,121,698 | -20.6% | 46,732 | +2.3% | 0.00% | -50.0% |
| Q3 2022 | $3,934,000 | -9.1% | 45,687 | -5.8% | 0.00% | 0.0% |
| Q2 2022 | $4,327,000 | -17.4% | 48,495 | +4.1% | 0.00% | 0.0% |
| Q1 2022 | $5,238,000 | -27.8% | 46,565 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $7,259,000 | +14.4% | 46,997 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $6,346,000 | +81.0% | 45,547 | +70.4% | 0.00% | +100.0% |
| Q2 2021 | $3,507,000 | -25.9% | 26,732 | -13.8% | 0.00% | -50.0% |
| Q1 2021 | $4,730,000 | +109.0% | 31,027 | +36.4% | 0.00% | +100.0% |
| Q4 2020 | $2,263,000 | +3.9% | 22,753 | -0.5% | 0.00% | 0.0% |
| Q3 2020 | $2,179,000 | -12.9% | 22,864 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $2,503,000 | +63.2% | 22,377 | +6.1% | 0.00% | 0.0% |
| Q1 2020 | $1,534,000 | -40.4% | 21,095 | -14.6% | 0.00% | 0.0% |
| Q4 2019 | $2,575,000 | +2.7% | 24,690 | -2.3% | 0.00% | 0.0% |
| Q3 2019 | $2,508,000 | -6.8% | 25,268 | +7.1% | 0.00% | 0.0% |
| Q2 2019 | $2,692,000 | -10.9% | 23,590 | -1.9% | 0.00% | -50.0% |
| Q1 2019 | $3,023,000 | 0.0% | 24,041 | +7.9% | 0.00% | 0.0% |
| Q4 2018 | $3,023,000 | -78.1% | 22,276 | -55.7% | 0.00% | -80.0% |
| Q3 2018 | $13,789,000 | +42.7% | 50,256 | +7.9% | 0.01% | +42.9% |
| Q2 2018 | $9,666,000 | +30.9% | 46,596 | +3.6% | 0.01% | +16.7% |
| Q1 2018 | $7,383,000 | +27.8% | 44,982 | +6.6% | 0.01% | +50.0% |
| Q4 2017 | $5,779,000 | +3.5% | 42,190 | +2.8% | 0.00% | 0.0% |
| Q3 2017 | $5,583,000 | +22.9% | 41,023 | +9.6% | 0.00% | 0.0% |
| Q2 2017 | $4,543,000 | +28.6% | 37,427 | +12.1% | 0.00% | +33.3% |
| Q1 2017 | $3,533,000 | +5.6% | 33,398 | +1.4% | 0.00% | 0.0% |
| Q4 2016 | $3,347,000 | +89.5% | 32,933 | +90.1% | 0.00% | +50.0% |
| Q3 2016 | $1,766,000 | +233.8% | 17,320 | +294.4% | 0.00% | +100.0% |
| Q2 2016 | $529,000 | +22.2% | 4,391 | +8.5% | 0.00% | – |
| Q1 2016 | $433,000 | +19.9% | 4,048 | +20.6% | 0.00% | – |
| Q4 2015 | $361,000 | +24.5% | 3,356 | 0.0% | 0.00% | – |
| Q3 2015 | $290,000 | -13.4% | 3,356 | 0.0% | 0.00% | – |
| Q2 2015 | $335,000 | +11.7% | 3,356 | -14.8% | 0.00% | – |
| Q1 2015 | $300,000 | +75.4% | 3,937 | +22.0% | 0.00% | – |
| Q4 2014 | $171,000 | +8.9% | 3,227 | -3.6% | 0.00% | – |
| Q3 2014 | $157,000 | – | 3,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |